BlackRock’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.2K Hold
49,650
﹤0.01% 4940
2025
Q1
$25.8K Hold
49,650
﹤0.01% 5006
2024
Q4
$25.3K Hold
49,650
﹤0.01% 5008
2024
Q3
$176K Buy
49,650
+2
+0% +$7 ﹤0.01% 4506
2024
Q2
$393K Hold
49,648
﹤0.01% 4354
2024
Q1
$673K Sell
49,648
-372
-0.7% -$5.04K ﹤0.01% 4242
2023
Q4
$541K Sell
50,020
-5
-0% -$54 ﹤0.01% 4334
2023
Q3
$325K Sell
50,025
-129
-0.3% -$839 ﹤0.01% 4480
2023
Q2
$903K Buy
50,154
+795
+2% +$14.3K ﹤0.01% 4232
2023
Q1
$1.16M Sell
49,359
-4,964
-9% -$117K ﹤0.01% 4202
2022
Q4
$1.36M Sell
54,323
-31,259
-37% -$781K ﹤0.01% 4225
2022
Q3
$2.72M Sell
85,582
-1,317
-2% -$41.9K ﹤0.01% 3953
2022
Q2
$3.43M Buy
86,899
+398
+0.5% +$15.7K ﹤0.01% 3903
2022
Q1
$3.48M Buy
86,501
+593
+0.7% +$23.9K ﹤0.01% 4060
2021
Q4
$4.34M Buy
85,908
+31,432
+58% +$1.59M ﹤0.01% 3989
2021
Q3
$3.54M Buy
54,476
+446
+0.8% +$29K ﹤0.01% 4016
2021
Q2
$2.09M Sell
54,030
-9,480
-15% -$367K ﹤0.01% 4180
2021
Q1
$3.33M Buy
63,510
+18,629
+42% +$978K ﹤0.01% 4054
2020
Q4
$3.05M Buy
44,881
+137
+0.3% +$9.32K ﹤0.01% 3818
2020
Q3
$1.71M Buy
44,744
+653
+1% +$25K ﹤0.01% 3853
2020
Q2
$1.7M Buy
44,091
+312
+0.7% +$12.1K ﹤0.01% 3791
2020
Q1
$1.31M Buy
43,779
+2,801
+7% +$84.1K ﹤0.01% 3717
2019
Q4
$4.65M Buy
40,978
+27,852
+212% +$3.16M ﹤0.01% 3476
2019
Q3
$414K Buy
13,126
+446
+4% +$14.1K ﹤0.01% 4153
2019
Q2
$543K Buy
12,680
+608
+5% +$26K ﹤0.01% 4116
2019
Q1
$658K Buy
12,072
+6,260
+108% +$341K ﹤0.01% 3990
2018
Q4
$173K Buy
5,812
+3,460
+147% +$103K ﹤0.01% 4214
2018
Q3
$108K Hold
2,352
﹤0.01% 4381
2018
Q2
$51K Sell
2,352
-48,081
-95% -$1.04M ﹤0.01% 4504
2018
Q1
$1.93M Sell
50,433
-177
-0.3% -$6.77K ﹤0.01% 3642
2017
Q4
$2.94M Buy
50,610
+1,684
+3% +$97.7K ﹤0.01% 3546
2017
Q3
$3.23M Buy
48,926
+997
+2% +$65.8K ﹤0.01% 3528
2017
Q2
$4.05M Buy
+47,929
New +$4.05M ﹤0.01% 3477